Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Right Turn: CRISPR, at a theatre near you
Does it seem like CRISPR is everywhere these days? That’s because it is! The popular gene editing tool – Clustered Regularly Interspaced Short Palindromic Repeats – is significant for its ability to edit DNA at precise locations, making it possible to correct mutations in the human genome to treat diseases caused by genetic defects. It […]
Will THIW become the next TIFF?
For those who aren’t familiar with THIW, there are parties but no films getting their world premieres. The comparison I’m making in the title is to the fact THIW is becoming a must-attend week-long event, with so much going on from morning to night, that serious THIW-goers may one year need to block their work […]
Right Turn: Talking gene therapies at StemCellTalks McMaster
This week (April 15-21) is National Volunteer Week. Across Canada, 12.7 million people donate their time to make Canada a better place to live. In the stem cell community, scientists, clinicians, researchers and hundreds of university students across the country work hard to make StemCellTalks a success every year. In the spirit of National Volunteer […]